MMM. Anthony Moody

M. Anthony Moody

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


M. Anthony Moody has a total of 575 co-authors. Here are the top co-authors by number of shared publications:

  • Barton F. Haynes

    Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC 27710, USA

    16 shared publications
  • Hua-Xin Liao

    Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC 27710, USA

    12 shared publications
  • David C. Montefiori

    Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC 27710, USA

    11 shared publications
  • Barton F. Haynes

    Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC 27710, USA

    8 shared publications
  • Georgia D. Tomaras

    Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC 27710, USA

    8 shared publications
  • Mattia Bonsignori

    Translational Immunobiology Unit, Laboratory of Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health 8 , Bethesda, MD

    8 shared publications

Latest Publications

  • Open Access

    Elicitation of stem-directed antibodies in rhesus macaques by a conventional hemagglutinin immunogen

    by Shuqin Gu, Joel Finney, Kan Luo, Sarah M. Valencia, Dieter Mielke, Tarra A. Von Holle, Dawn J. Marshall, Robert Parks, Laura L. Sutherland, Richard M. Scearce, et al.

    Because they can bind many strains of influenza, antibodies targeting the hemagglutinin (HA) stem have been attractive targets for vaccine development. Many monoclonal antibodies (mAbs) directed at the HA stem have been isolated from humans, and these mAbs have mediated broad protection in animal models. We describe here HA stem-directed mAbs isolated from rhesus macaques immunized with an “ordinary” H1 HA trimer. All immunized rhesus macaques developed high serum titers with broad reactivity to diverse H1N1 and H5N1 viruses, and 7 isolated mAbs strongly blocked canonical stem antibody CR6261 binding to H1. MAb DH726.1 robustly protected mice from lethal challenge with H1N1 and H5N1 viruses, and cryo-EM showed the binding footprint overlapped that of some human mAbs. These findings suggest that vaccination with the standard, trimeric HA immunogens may be sufficient to elicit stem antibodies at titers adequate to protect against zoonotic H5N1 influenza. In Brief: Efforts to achieve broad influenza protection have largely emphasized increasingly sophisticated immunogen designs to redirect antibody responses toward conserved epitopes. Here, we show that a single, conventional HA immunogen readily elicits antibodies targeting the conserved HA stem, suggesting that routine influenza vaccination may provide broader protection than previously appreciated. Highlights: Monovalent HA immunization induces strong, stem-directed immune responses in rhesus macaques Epitope on the HA stem confirmed by Cryo-EM Fc-mediated activation of immune effector cell by rhesus-derived stem mAb HA stem-directed antibody protects mice against H1N1 and H5N1 viruses Abstract Figure:

  • Open Access

    Strain Agnostic Influenza Virus Propagation in a Serum‐Free, Suspension‐Adapted MDCK Cell Line

    by Jessica B. Huskey, Michelle L. Rock, Pooja V. Chaudhary, Emily C. Hill, Madeline E. Hoover, Nicole M. Rideout, Kamerin D. Dean, Thomas Scott Alderman, Phong Ho, M. Anthony Moody, et al.

    Background: The continuing circulation and evolution of seasonal influenza viruses remains a public health and socioeconomic threat on a global scale. Viral surveillance and vaccination of the public have been relied upon to confer and boost immunity in the population. Traditionally, influenza strains are propagated in embryonated chicken eggs, but this process remains imperfect and subject to genetic drift of the virus and a reliable source of eggs. Cell culture‐based propagation of influenza virus has recently been commercialized, but this method has been difficult to adapt to lab settings. Methods: Madin‐Darby canine kidney (MDCK) cells were adapted to thrive in serum‐free growth in suspension. The suspension MDCK (sMDCK) line was characterized by measuring replication and viability during routine passage and infection. Fifteen different influenza strains were propagated using this model and were assayed to determine hemagglutination and plaque forming units and compared to influenza strains grown in adherent cell culture. Microneutralization tests were also conducted to ensure each strain maintained the proper antigenicity. Results: The cell line was successfully adapted to serum‐free growth in suspension. For each virus strain, the sMDCK platform successfully produced a virus stock in 1–3 days. Additionally, sMDCK progeny virus maintained its antigenicity based on neutralization assays. Conclusions: This simple, scalable method was used to reliably propagate 15 influenza strains with the elimination of costly reagents and animal serum. The results are comparable to traditional methods, and the protocol presented in this work could be adapted to nearly any laboratory setting.

  • Open Access

    Erratum to “Gene discovery and expression analysis of the B cell receptor repertoire in the domestic ferret model” [Vaccine 64 (2025) 127725]

    by Luke S. Hebert, Whitney Pickens, Ed Satterwhite, Gabriel B. Soto, Franziska M. Pflaum, Michael Zhan, M. Anthony Moody, Jessica Kain, Greg A. Kirchenbaum, James A. Ferguson, et al.

  • Open Access

    Functional Convergence of Genetically Diverse B-Cell Receptors in Simian-HIV Infected Rhesus Macaques

    by Shengli Song, Hui Li, Chen-Hao Yeh, Akiko Watanabe, Masayuki Kuraoka, Hongmei Gao, Xiaoying Shen, Celia C. LaBranche, Wilton B. Williams, Kevin O. Saunders, et al.

    SUMMARY: Germline-targeting or lineage-based vaccine strategies are being used to induce HIV broadly neutralizing antibody (bnAb) responses. These strategies assume that genetically diverse individuals respond similarly to the same immunogen by mobilizing comparable germline precursors, although outcomes vary across bnAb epitopes. Here we explored this premise using a simian-HIV infection model in rhesus macaques. Antigen-unbiased Env-reactive B-cell populations were profiled, followed by systematic analysis of antibody function and B-cell receptor (BCR) genetics. We find that while global Env-reactive B-cell response profiles and antibody functional properties are similar across individuals, underlying BCR genetics are diverse, particularly among non-bnAbs. These results indicate that functional convergence of Env-reactive antibody responses does not necessarily require genetic convergence and suggest that specific germline-targeting may not be an absolute prerequisite for successful vaccine design. These findings support an epitope-focused framework in which bnAb epitopes are engineered to enhance population-level immunogenicity, with potential applicability to other challenging pathogens.


  • Open Access

    Gene discovery and expression analysis of the B cell receptor repertoire in the domestic ferret model

    by Luke S. Hebert, Whitney Pickens, Ed Satterwhite, Gabriel B. Soto, Franziska M. Pflaum, Michael Zhan, M. Anthony Moody, Jessica Kain, Greg A. Kirchenbaum, James A. Ferguson, et al.


  • Open Access

    Transient regulatory T cell manipulation is limited by anti-antibody responses in HIV-1 envelope immunized rhesus macaques

    by Shuqin Gu, Kan Luo, Tarra A. Von Holle, Thaddeus C. Gurley, Hilary Bouton-Verville, Laura L. Sutherland, Robert Parks, Xiaoying Shen, Rachel L. Spreng, Georgia D. Tomaras, et al.


  • Top Cited Papers

    Disease diagnostics using machine learning of B cell and T cell receptor sequences

    by Maxim E. Zaslavsky, Erin Craig, Jackson K. Michuda, Nidhi Sehgal, Nikhil Ram-Mohan, Ji-Yeun Lee, Khoa D. Nguyen, Ramona A. Hoh, Tho D. Pham, Katharina Röltgen, et al.

    Clinical diagnosis typically incorporates physical examination, patient history, various laboratory tests, and imaging studies but makes limited use of the human immune system’s own record of antigen exposures encoded by receptors on B cells and T cells. We analyzed immune receptor datasets from 593 individuals to develop MAchine Learning for Immunological Diagnosis, an interpretive framework to screen for multiple illnesses simultaneously or precisely test for one condition. This approach detects specific infections, autoimmune disorders, vaccine responses, and disease severity differences. Human-interpretable features of the model recapitulate known immune responses to severe acute respiratory syndrome coronavirus 2, influenza, and human immunodeficiency virus, highlight antigen-specific receptors, and reveal distinct characteristics of systemic lupus erythematosus and type-1 diabetes autoreactivity. This analysis framework has broad potential for scientific and clinical interpretation of immune responses.


  • Open Access

    Fluorescence-barcoded cell lines stably expressing membrane-anchored influenza neuraminidases

    by Joel Finney, Masayuki Kuraoka, Shengli Song, Akiko Watanabe, Xiaoe Liang, Dongmei Liao, M. Anthony Moody, Emmanuel B. Walter, Stephen C. Harrison, Garnett H Kelsoe

    The discovery of broadly protective antibodies to the influenza virus neuraminidase (NA) has raised interest in NA as a vaccine target. However, recombinant, solubilized tetrameric NA ectodomains are often challenging to express and isolate, hindering the study of anti-NA humoral responses. To address this obstacle, we established a panel of 22 non-adherent cell lines stably expressing native, historical N1, N2, N3, N9, and NB NAs anchored on the cell surface. The cell lines are barcoded with fluorescent proteins, enabling high-throughput, 16-plex analyses of antibody binding with commonly available flow cytometers. The cell lines were at least as efficient as a Luminex multiplex binding assay at identifying NA antibodies from a library of unselected clonal IgGs derived from human memory B cells. The cell lines were also useful for measuring the magnitude and breadth of the serum antibody response elicited by experimental infection of rhesus macaques with influenza virus. The membrane-anchored NAs are catalytically active and are compatible with established sialidase activity assays. NA-expressing K530 cell lines therefore represent a useful tool for studying NA immunity and evaluating influenza vaccine efficacy.

  • Open Access

    Transient inhibition of lysosomal functions potentiates nucleic acid vaccines

    by Chunxi Wang, Amelia Karlsson, Thomas H. Oguin, Andrew N. Macintyre, Gregory D. Sempowski, Kevin R. McCarthy, Yifei Wang, M. Anthony Moody, Fan Yuan

    Nucleic acid vaccines have shown promising results in the clinic against infectious diseases and cancers. To robustly improve the vaccine efficacy and safety, we developed an approach to increase the intracellular stability of nucleic acids by transiently inhibiting lysosomal function in targeted tissues using sucrose. To achieve efficient and localized delivery of sucrose in animals, we designed a biomimetic lipid nanoparticle (LNP) to target the delivery of sucrose into mouse muscle cells. Using this approach, viral antigen expression in mouse muscle after DNA vaccination was substantially increased and prolonged without inducing local or systemic inflammation or toxicity. The same change in antigen expression would be achieved if the vaccine dose could be increased by 3,000 folds, which is experimentally and clinically impractical due to material restrictions and severe toxicity that will be induced by such a high dose of nucleic acids. The increase in antigen expression augmented the infiltration and activation of antigen-presenting cells, significantly improved vaccine-elicited humoral and T cell responses, and fully protected mice against the viral challenge at a low dose of vaccine. Based on these observations, we conclude that transient inhibition of lysosome function in target tissue by sucrose LNPs is a safe and potent approach to substantially improve nucleic acid-based vaccines.


  • Open Access

    Can ChatGPT/GPT-4 assist surgeons in confronting patients with Mpox and handling future epidemics?

    by Yongbin He, Haiyang Wu, Yan Chen, Dewei Wang, Weiming Tang, M. Anthony Moody, Guoxin Ni, Shuqin Gu

    An abstract is unavailable. This article is available as a PDF only.